You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Histone Deacytelase Inhibitors

Showing 26 - 50 of 4,414
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Heart Failure With Normal Ejection Fraction, Left Ventricular Hypertrophy, Aortic Valve Stenosis Trial in Boston

Recruiting
  • Heart Failure With Normal Ejection Fraction
  • +3 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Mar 1, 2022

Advanced Breast Cancer Trial in Beijing (The combination of Dalpiciclib with physician-selected endocrine therapy, Chemotherapy

Recruiting
  • Advanced Breast Cancer
  • The combination of Dalpiciclib with physician-selected endocrine therapy
  • Chemotherapy selected by the physician
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
May 22, 2023

Glioma Trial in United States (ONC201)

Active, not recruiting
  • Glioma
  • San Francisco, California
  • +8 more
Jul 14, 2022

SGLT-2 Inhibitors on Epicardial Adipose Tissue and Cardiac

Recruiting
  • Coronary Artery Disease
  • Sodium Glucose Co-transporter 2 (SGLT2) Inhibitor
  • Shah Alam, Selangor, Malaysia
    Institute for Clinical Research, National Institutes of Health,
Nov 9, 2023

Musculoskeletal Health in Breast Cancer During Aromatase

Recruiting
  • Musculoskeletal Health
  • No intervention
  • Shanghai, Shanghai, China
    School of Nursing, Fudan University
Jun 16, 2023

Lymphoma, Follicular Trial in China (Abexinostat)

Recruiting
  • Lymphoma, Follicular
  • Beijing, China
  • +25 more
Mar 3, 2022

Kabuki Syndrome Trial in Baltimore (Modified Atkins diet)

Recruiting
  • Kabuki Syndrome
  • Modified Atkins diet
  • Baltimore, Maryland
    Kennedy Krieger Institute
Nov 17, 2022

Bile Acids in Acute Insulin Resistance

Recruiting
  • PI3K Gene Mutation
  • +4 more
  • Drug-induced acute insulin resistance due to PI3K inhibitor, AKT inhibitor, or mTOR inhibitor
  • New York, New York
    Columbia University Medical Center
Oct 6, 2022

ICIs Plus Angiogenesis Inhibitors for Treatment of Advanced

Completed
  • NSCLC
  • Immune checkpoint inhibitors plus angiogenesis inhibitors
  • Immune checkpoint inhibitors without angiogenesis inhibitors
  • Suzhou, Jiangsu, China
    The Affiliated Suzhou Hospital of Nanjing Medical University
Jan 17, 2023

Solid Tumor, ARID1A Gene Mutation Trial in Greenville (Tazemetostat)

Suspended
  • Solid Tumor
  • ARID1A Gene Mutation
  • Greenville, South Carolina
    Prisma Health Cancer Institute
Jan 10, 2023

Breast Feeding, Hypertension, Heart Failure Trial in Leuven (Venipuncture)

Recruiting
  • Breast Feeding
  • +3 more
  • Venipuncture
  • Leuven, Vlaams-Brabant, Belgium
    Universitaire Ziekenhuizen Leuven
Oct 12, 2023

Acute Esophageal Variceal Hemorrhage Trial in Hanzhou (Growth Inhibitor)

Recruiting
  • Acute Esophageal Variceal Hemorrhage
  • Growth Inhibitor
  • Hanzhou, Zhejiang, China
    2nd Affiliated Hospital, School of Medicine, Zhejiang University
Aug 22, 2023

Hodgkin's Lymphoma Trial in Milano (ITF2357)

Completed
Has Results
  • Hodgkin's Lymphoma
  • Milano, Italy
    Istituto Nazionale per la Cura e lo Studio dei Tumori
Apr 20, 2021

Heart Failure, Heart Failure With Reduced Ejection Fraction Trial in Danville (Pharmacist co-management, CDS, Focused Education)

Recruiting
  • Heart Failure
  • Heart Failure With Reduced Ejection Fraction
  • Pharmacist co-management
  • +2 more
  • Danville, Pennsylvania
    Geisinger Cardiology Clinics
Aug 11, 2023

Gastroesophageal Reflux, Regurgitation, Heartburn Trial in Jacksonville (Breath Testing)

Not yet recruiting
  • Gastroesophageal Reflux
  • +2 more
  • Breath Testing
  • Jacksonville, Florida
    Mayo Clinic Florida
Jul 27, 2023

Gastric Adenocarcinoma Trial (cadonilimab combined +paclitaxel (albumin-bound))

Not yet recruiting
  • Gastric Adenocarcinoma
  • cadonilimab combined +paclitaxel (albumin-bound)
  • (no location specified)
Nov 1, 2023

Hepatocellular Carcinoma, Recurrence, Immune Checkpoint Inhibitor Trial in Nanning (Adjuvant tislelizumab plus lenvatinib,

Not yet recruiting
  • Hepatocellular Carcinoma
  • +2 more
  • Adjuvant tislelizumab plus lenvatinib
  • Adjuvant tislelizumab
  • Nanning, China
    Jian-Hong Zhong
Jun 11, 2023

Cancer of the Colon Trial in Marseille (BLOOD AND TUMOR)

Recruiting
  • Cancer of the Colon
  • BLOOD AND TUMOR
  • Marseille, France
    Institut Paoli Calmettes
Jul 12, 2023

SGLT-2 Inhibitors in the Treatment of Ascites

Recruiting
  • Ascites Hepatic
  • +2 more
  • SGLT2 inhibitor
  • Palermo, Italy
  • +1 more
Aug 11, 2023

Leukemia, Leukemia, Acute, Leukemia, Lymphoblastic Trial in Guangzhou (Chidamide, Dasatinib)

Recruiting
  • Leukemia
  • +3 more
  • Guangzhou, Guangdong, China
    Department of Hematology, Nanfang Hospital
Jun 28, 2022

Metastatic Breast Cancer, Advanced Breast Cancer, Quality of Life Trial in Worldwide (CDK 4/6 inhibitors, Endocrine therapy)

Not yet recruiting
  • Metastatic Breast Cancer
  • +4 more
  • CDK 4/6 inhibitors
  • Endocrine therapy
  • Helsinki, Finland
  • +11 more
Sep 19, 2023

Bladder Cancer Trial in Chapel Hill, Philadelphia (Pembrolizumab, Entinostat)

Recruiting
  • Bladder Cancer
  • Chapel Hill, North Carolina
  • +1 more
Oct 10, 2022

Fruquintinib With PD-1 Inhibitors Versus TAS-102 With

Completed
  • Metastatic Colorectal Adenocarcinoma
  • Changsha, Hunan, China
    Hunan Cancer hospital
Sep 2, 2023

DNA Methylation and Histone Modification in H. Pylori Associated

Recruiting
  • Gastric Carcinoma
  • Immunohistochemical staining for DNMT1 and EZH2
  • Assiut, Egypt
    Assiut University
Mar 31, 2023

Checkpoint Inhibitors in Solid Tumors:Retrospective Real-world

Recruiting
  • Immunotherapy
    • Nanjing, Jiangsu, China
      The First Affiliated Hospital with Nanjing Medical University
    Feb 8, 2023